CLINICAL_TRIALS
trial_result
· 2012-10-11
Clinical Trial Update: Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan [Phase 3]
Summary
A Phase 3 trial in Japan evaluating Ono Pharmaceutical's ONO-8025 (KRP-197) for overactive bladder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED